BACE1 and Alzheimer disease: In a case–control and longitudinal study at a specialized memory clinic, where the patients were followed for 3–6 years, CSF BACE1 activity was significantly higher in Alzheimer’s disease patients than in normal control subjects [31] (Table 1).